Insulin Analog [EPC]

241192 reported adverse events

Drugs of this class: INSULIN LISPRO INSULIN GLARGINE INSULIN DETEMIR INSULIN GLARGINE AND LIXISENATIDE INSULIN GLULISINE INSULIN LISPRO-AABC

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 51367
1 BLOOD GLUCOSE DECREASED 12827
2 DRUG INEFFECTIVE 11757
3 NAUSEA 9921
4 HYPOGLYCAEMIA 8375
5 INCORRECT DOSE ADMINISTERED 7829
6 MALAISE 7703
7 VISUAL IMPAIRMENT 7313
8 DRUG DOSE OMISSION 6681
9 FATIGUE 6554
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 1676 0.8858
1 HYPOGLYCAEMIA UNAWARENESS 190 0.6129
2 ANTI-INSULIN ANTIBODY POSITIVE 115 0.5665
3 HYPOGLYCAEMIC UNCONSCIOUSNESS 923 0.5537
4 INTERCEPTED PRODUCT SELECTION ERROR 256 0.5344
5 HYPOGLYCAEMIC SEIZURE 332 0.4486
6 BLOOD KETONE BODY 118 0.4470
7 DIABETIC RETINOPATHY 959 0.4214
8 DIABETIC HYPERGLYCAEMIC COMA 103 0.4170
9 SHOCK HYPOGLYCAEMIC 155 0.4068
See all enriched reactions for Insulin Analog [EPC]